Gastrointestinal Issues This is where BPC-157 started, and its still one of its strongest applications
Mechanism map How BPC-157 is positioned BPC-157 (Body Protection Compound-157) is a pentadecapeptide derived from human gastric juice
This emerging molecule is being explored as a GLP-1, GIP, and glucagon triple-agonist peptide , placing it in the same rapidly growing category as Retatrutide , one of the most talked-about compounds in the metabolic research pipeline
In response to the explosion of the unregulated peptides market, the MHRA, the body responsible for licensing and overseeing the use of medicines in the UK, says that it does not "accept attempts to evade medicines regulation" by selling peptides for "research purposes" where evidence indicates they are being used by people
PEGylated exendin-4, a modified GLP-1 analog exhibits more potent cardioprotection than its unmodified parent molecule on a dose to dose basis in a murine model of myocardial infarction
GHK-Cu synergized with targeted nutrients or therapies can further enhance results in some scenarios